Multiple Myeloma
Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bo...
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg
2011.
|
| Colección: | Recent Results in Cancer Research ;
183. Springer eBooks. |
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b32889227*spi |
Tabla de Contenidos:
- History and epidemiology
- Pathophysiology: Molecular biology of plasma cell disorders. Alterations in microenvironment
- Clinical Features: Imaging. Integrated innovative approach for diagnosis and staging
- Therapy: High-dose chemotherapy and ABSCT
- Allogeneic transplantation. Novel Drugs
- Immunotherapeutic approaches
- First-line treatment and maintenance
- Relapse
- Radiotherapy
- Kyphoplasty
- Supportive Therapy
- Appendix: Staging and prognosis systems.
